九典制药(300705.SZ)两种药品获准开展临床试验

Core Viewpoint - The company has received approval from the National Medical Products Administration for clinical trials of two drugs, indicating progress in its research and development efforts [1] Group 1 - The company has obtained a clinical trial approval notice for JIZM01, which is intended for the treatment of closed soft tissue contusions and joint sprains [1] - The clinical trial for JIZM02 has been approved, targeting adhesive capsulitis of the shoulder [1]